Analysis of microRNA and gene networks in human chronic myelogenous leukemia

Wang,Kunhao; Xu,Zhiwen; Wang,Ning; Tian,Ye; Sun,Xin; Ma,Yonggang

doi:10.3892/mmr.2015.4502

Analysis of microRNA and gene networks in human chronic myelogenous leukemia

Authors:
- Kunhao Wang
- Zhiwen Xu
- Ning Wang
- Ye Tian
- Xin Sun
- Yonggang Ma
View Affiliations

Affiliations: School of Information Engineering, Changchun University of Science and Technology, Changchun, Jilin 130600, P.R. China, College of Computer Science and Technology, Jilin University, Changchun, Jilin 130012, P.R. China, School of Computer Science and Technology, Changchun University of Science and Technology, Changchun, Jilin 130022, P.R. China, College of Information Science and Engineering, Ocean University of China, Qingdao, Shandong 266100, P.R. China, College of Science, Dalian Ocean University, Dalian, Liaoning 116023, P.R. China
Published online on: November 5, 2015 https://doi.org/10.3892/mmr.2015.4502
Pages: 453-460

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Molecular biologists have identified a number of genes and microRNAs (miRs) associated with chronic myelogenous leukemia (CML). However, their underlying mechanisms in CML remain unclear. In the present study, three regulatory networks of genes and miRs were constructed to elucidate the underlying mechanisms of CML. The first network was the experimentally validated network of miRs and genes. The second was the dysregulatory network of CML, consisting of dysregulated genes and miRs, contributing to the pathogenesis of CML. The third was the CML‑associated network, consisting of CML‑associated genes and miRs. In addition to dysregulated genes and miRs, the associated network includes non‑dysregulated genes and miRs that contribute to prevention, diagnosis, metastasis and therapy of CML. Key pathways were extracted and compared to distinguish the similarities and differences between dysregulatory nodes among the three networks. V-myb avian myeloblastosis viral oncogene homolog and miR‑155 were observed to form a feedback loop module in the dysregulatory network. Regulation of the dysregulatory network may present as a strategy for gene therapy of CML. The current study provides an improved understanding of the molecular mechanisms of, and a potential treatment strategy for, CML.

View Figures

View References

1	Vardiman JW: The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: An overview with emphasis on the myeloid neoplasms. Chem Biol Interact. 184:16–20. 2010. View Article : Google Scholar
2	Kęsy J and Januszkiewicz-Lewandowska D: Genes and childhood leukemia. Postepy Hig Med Dosw (Online). 69:302–308. 2015. View Article : Google Scholar
3	Gao S, Bajrami I, Verrill C, Kigozi A, Ouaret D, Aleksic T, Asher R, Han C, Allen P, Bailey D, et al: Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling. Cancer Res. 74:5866–5877. 2014. View Article : Google Scholar : PubMed/NCBI
4	Rokah OH, Granot G, Ovcharenko A, Modai S, Pasmanik-Chor M, Toren A, Shomron N and Shpilberg O: Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells. PLoS One. 7:e355012012. View Article : Google Scholar : PubMed/NCBI
5	Yamaguchi H, Inokuchi K, Sakuma Y and Dan K: Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia. Leukemia. 15:1729–1734. 2001. View Article : Google Scholar : PubMed/NCBI
6	Agirre X, Jiménez-Velasco A, San José-Enériz E, Garate L, Bandrés E, Cordeu L, Aparicio O, Saez B, Navarro G, Vilas-Zornoza A, et al: Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol Cancer Res. 6:1830–1840. 2008. View Article : Google Scholar : PubMed/NCBI
7	Miething C, Grundler R, Mugler C, Brero S, Hoepfl J, Geigl J, Speicher MR, Ottmann O, Peschel C and Duyster J: Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment. Proc Natl Acad Sci USA. 104:4594–4599. 2007. View Article : Google Scholar : PubMed/NCBI
8	Yu Y, Yang L, Zhao M, Zhu S, Kang R, Vernon P, Tang D and Cao L: Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells. Leukemia. 26:1752–1760. 2012. View Article : Google Scholar : PubMed/NCBI
9	Hobert O: Gene regulation by transcription factors and microRNAs. Science. 319:1785–1786. 2008. View Article : Google Scholar : PubMed/NCBI
10	Latchman DS: Transcription factors: An overview. Int J Biochem Cell Biol. 29:1305–1312. 1997. View Article : Google Scholar
11	Chen K and Rajewsky N: The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet. 8:93–103. 2007. View Article : Google Scholar : PubMed/NCBI
12	Betel D, Wilson M, Gabow A, Marks DS and Sander C: The http://microRNA.orgurisimplemicroRNA.org resource: Targets and expression. Nucleic Acids Res. 36(Database): D149–D153. 2008. View Article : Google Scholar
13	Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20. 2005. View Article : Google Scholar : PubMed/NCBI
14	Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M and Rajewsky J: Combinatorial microRNA target predictions. Nat Genet. 37:495–500. 2005. View Article : Google Scholar : PubMed/NCBI
15	Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P and Hatzigeorgiou AG: The database of experimentally supported targets: A functional update of TarBase. Nucleic Acids Res. 37(Database): D155–D158. 2009. View Article : Google Scholar :
16	Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, Chan WL, Tsai WT, Chen GZ, Lee CJ, Chiu CM, et al: miRTarBase: A database curates experimentally validated microRNA-target interactions. Nucleic Acids Res. 39(Database): D163–D169. 2011. View Article : Google Scholar
17	Xiao F, Zuo Z, Cai G, Kang S, Gao X and Li T: miRecords: An integrated resource for microRNA-target interactions. Nucleic Acids Res. 37(Database): D105–D110. 2009. View Article : Google Scholar
18	Rodriguez A, Griffiths-Jones S, Ashurst JL and Bradley A: Identification of mammalian microRNA host genes and transcription units. Genome Res. 14(10A): 1902–1910. 2004. View Article : Google Scholar : PubMed/NCBI
19	Baskerville S and Bartel DP: Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRs and host genes. RNA. 11:241–247. 2005. View Article : Google Scholar : PubMed/NCBI
20	Cao G, Huang B, Liu Z, Zhang J, Xu H, Xia W, Li J, Li S, Chen L, Ding H, et al: Intronic miR-301 feedback regulates its host gene, ska2, in A549 cells by targeting MEOX2 to affect ERK/CREB pathways. Biochem Biophy Res Commun. 396:978–982. 2010. View Article : Google Scholar
21	Vaidya S, Ghosh K, Shanmukhaiah C and Vundinti BR: Genetic variations of hOCT1 gene and CYP3A4/A5 genes and their association with imatinib response in Chronic Myeloid Leukemia. Eur J Pharmacol. 765:124–130. 2015. View Article : Google Scholar : PubMed/NCBI
22	Fallah P, Amirizadeh N, Poopak B, Toogeh G, Arefian E, Kohram F, Hosseini Rad SM, Kohram M, Teimori Naghadeh H and Soleimani M: Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Int J Lab Hematol. 37:560–568. 2015. View Article : Google Scholar : PubMed/NCBI
23	Wang J, Lu M, Qiu C and Cui Q: TransmiR: A transcription factor-microRNA regulation database. Nucleic Acids Res. 38(Database): D119–D122. 2010. View Article : Google Scholar
24	Chekmenev DS, Haid C and Kel AE: P-Match: transcription factor binding site search by combining patterns and weight matrices. Nucleic Acids Res. 33(Web Server): W432–W437. 2005. View Article : Google Scholar : PubMed/NCBI
25	Flamant S, Ritchie W, Guilhot J, Holst J, Bonnet ML, Chomel JC, Guilhot F, Turhan AG and Rasko JE: Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia. Haematologica. 95:1325–1333. 2010. View Article : Google Scholar : PubMed/NCBI
26	Kanehisa M and Goto S: KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30. 2000. View Article : Google Scholar
27	Dong W, Zhang J, Shao N, Tian T, Li L, Jian J, Zang S, Ma D and Ji C: Development and immunological evaluation of HLA-specific chronic myeloid leukemia polyepitope vaccine in Chinese population. Vaccine. 32:3501–3508. 2014. View Article : Google Scholar : PubMed/NCBI
28	Sekiguchi Y, Shimada A, Matsuzawa M, Imai H, Wakabayashi M, Sugimoto K, Nakamura N, Sawada T, Arita J, Komatsu N and Noguchi M: Occurrence of carcinoma of the pancreas following nilotinib therapy for chronic myeloid leukemia: Report of a case with review of the literature. Turk J Haematol. 32:257–262. 2015. View Article : Google Scholar : PubMed/NCBI
29	Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, Nativ N, Bahir I, Doniger T and Krug H: GeneCards version 3: The human gene integrator. Database (Oxford). baq0202010.
30	Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, Cline MS, Goldman M, Barber GP, Clawson H and Coelho A: The UCSC Genome Browser database: Update 2011. Nucleic Acids Res. 39(Database): D876–D882. 2011. View Article : Google Scholar :
31	Matys V, Fricke E, Geffers R, Gössling E, Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE, Kel-Margoulis OV, et al: TRANSFAC: Transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 31:374–378. 2003. View Article : Google Scholar : PubMed/NCBI
32	Li Y, Qiu C, Tu J, Geng B, Yang J, Jiang T and Cui Q: HMDD v2.0: A database for experimentally supported human microRNA and disease associations. Nucleic Acids Res. 42(D1): D1070–D1074. 2014. View Article : Google Scholar :
33	Tzoanopoulos D, Speletas M, Arvanitidis K, Veiopoulou C, Kyriaki S, Thyphronitis G, Sideras P, Kartalis G and Ritis K: Low expression of interferon regulatory factor-1 and identification of novel exons skipping in patients with chronic myeloid leukaemia. Br J Haematol. 119:46–53. 2002. View Article : Google Scholar : PubMed/NCBI
34	Zhao LJ, Wang YY, Li G, Ma LY, Xiong SM, Weng XQ, Zhang WN, Wu B, Chen Z and Chen SJ: Functional features of RUNX1 mutants in acute transformation of chronic myeloid leukemia and their contribution to inducing murine full-blown leukemia. Blood. 119:2873–2882. 2012. View Article : Google Scholar : PubMed/NCBI
35	Reuter S, Charlet J, Juncker T, Teiten MH, Dicato M and Diederich M: Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells. Ann N Y Acad Sci. 1171:436–447. 2009. View Article : Google Scholar : PubMed/NCBI
36	Ye H, Liu X, Lv M, Wu Y, Kuang S, Gong J, Yuan P, Zhong Z, Li Q, Jia H, et al: MicroRNA and transcription factor co-regulatory network analysis reveals miR-19 inhibits CYLD in T-cell acute lymphoblastic leukemia. Nucleic Acids Res. 40:5201–5214. 2012. View Article : Google Scholar : PubMed/NCBI
37	Nautiyal J, Du J, Yu Y, Kanwar SS, Levi E and Majumdar AP: EGFR regulation of colon cancer stem-like cells during aging and in response to the colonic carcinogen dimethylhydrazine. Am J Physiol Gastrointest Liver Physiol. 302:G655–G663. 2012. View Article : Google Scholar : PubMed/NCBI
38	Nagel S, Venturini L, Przybylski GK, Grabarczyk P, Schmidt CA, Meyer C, Drexler HG, Macleod RA and Scherr M: Activation of miR-17–92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia. Leuk Lymphoma. 50:101–108. 2009. View Article : Google Scholar : PubMed/NCBI